Cue Biopharma
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers (NCT05360680) | Cue Biopharma | 2022-06-14 |
| A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (NCT03978689) | Cue Biopharma | 2019-07-30 |
Track Cue Biopharma automatically
Every clearance here is in the API, with alerts when new ones post.